Chris Van den Haute Selected Research

Kufor-Rakeb syndrome

3/2021	ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization.
7/2015	A lipid switch unlocks Parkinson's disease-associated ATP13A2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chris Van den Haute Research Topics

Disease

22	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2006
6	Synucleinopathies 01/2020 - 02/2010
3	Glaucoma 01/2022 - 01/2015
3	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 04/2010
2	Parkinsonian Disorders (Parkinsonism) 03/2021 - 01/2011
2	Kufor-Rakeb syndrome 03/2021 - 07/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 06/2002
2	Seizures (Absence Seizure) 01/2021 - 11/2019
2	Temporal Lobe Epilepsy 01/2021 - 11/2019
2	Neuroinflammatory Diseases 01/2021 - 03/2015
2	Disease Progression 01/2021 - 01/2019
2	Rupture 12/2020 - 01/2020
2	Multiple Sclerosis 01/2020 - 03/2015
2	Cystic Fibrosis (Mucoviscidosis) 01/2016 - 06/2014
1	Melanoma (Melanoma, Malignant) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Hypersensitivity (Allergy) 12/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2020
1	Ischemia 11/2020
1	Multiple System Atrophy 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Dementia (Dementias) 01/2020
1	Epilepsy (Aura) 11/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Blindness (Hysterical Blindness) 01/2019
1	Vision Disorders (Hemeralopia) 01/2019
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2019
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 01/2016
1	Ocular Hypertension (Glaucoma, Suspect) 01/2015
1	Stroke (Strokes) 09/2014
1	Infarction (Infarctions) 09/2014
1	Neuroblastoma 11/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2011
1	Amyloid Plaque 05/2002
1	Alzheimer Disease (Alzheimer's Disease) 05/2002

Drug/Important Bio-Agent (IBA)

11	alpha-SynucleinIBA 01/2022 - 02/2010
8	SynucleinsIBA 01/2021 - 11/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
5	Phosphotransferases (Kinase)IBA 01/2021 - 08/2006
4	PolyaminesIBA 03/2021 - 01/2020
4	Leucine (L-Leucine)FDA Link 01/2021 - 08/2006
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2019
2	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 11/2019 - 01/2016
2	Surface-Active Agents (Surfactants)IBA 01/2016 - 06/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2015 - 02/2010
1	RNA (Ribonucleic Acid)IBA 01/2022
1	IronIBA 01/2021
1	Mitoguazone (MGBG)IBA 01/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA 01/2021
1	MitoTEMPOIBA 12/2020
1	SpermineIBA 12/2020
1	RotenoneIBA 12/2020
1	Ferritins (Ferritin)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 11/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2020
1	Glucosylceramides (Glucocerebrosides)IBA 01/2020
1	Cathepsin BIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2019
1	clozapine N-oxideIBA 11/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019
1	p21-Activated KinasesIBA 12/2015
1	CuprizoneIBA 10/2015
1	Oncostatin MIBA 10/2015
1	Adenosine Triphosphatases (ATPase)IBA 07/2015
1	LipidsIBA 07/2015
1	Leukemia Inhibitory FactorIBA 03/2015
1	Nerve Growth Factors (Neurotrophins)IBA 01/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	Neuroprotective AgentsIBA 01/2015
1	Firefly LuciferasesIBA 12/2014
1	NestinIBA 09/2014
1	endonuclease GIBA 11/2013
1	PTEN-induced putative kinaseIBA 04/2011
1	Dopamine (Intropin)FDA LinkGeneric 01/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2011
1	TensinsIBA 01/2011
1	Recombinant ProteinsIBA 04/2010
1	Tacrolimus Binding Proteins (FKBP)IBA 02/2010
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2006
1	Peptides (Polypeptides)IBA 05/2002
1	Amyloid (Amyloid Fibrils)IBA 05/2002
1	Presenilin-1IBA 05/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2014
1	Microspheres (Microsphere) 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 03/2015
1	Lasers (Laser) 01/2015